Human chimeric antigen receptor macrophages for cancer immunotherapy

Journal: Nature Biotechnology

Published: 2020-03-23

DOI: 10.1038/s41587-020-0462-y

Affiliations: 9

Authors: 26

Go to article
Institutions Share
Center for Cellular Immunotherapies (CCI), Penn, United States of America (USA) 0.56
Carisma Therapeutics Inc., United States of America (USA) 0.22
Department of Systems Pharmacology and Translational Therapeutics, Penn, United States of America (USA) 0.06
Department of Biochemistry and Biophysics, Penn, United States of America (USA) 0.06
Division of Hematology and Oncology, Penn Medicine, United States of America (USA) 0.03
Penn Institute for Biomedical Informatics (IBI), United States of America (USA) 0.02
Mayo Clinic Department of Hematology, United States of America (USA) 0.02
Division of Oncology, WUSTL, United States of America (USA) 0.02
Department of Pathology and Laboratory Medicine, Penn, United States of America (USA) 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER